What Happened
The UK's Personal Independence Payments (Pip) system, a key disability benefit, has been deemed "not fit for purpose" by Sir Stephen Timms, the minister leading a review into the system. The review found that the process of applying for the benefit was "dehumanising" and a barrier to work. In other news, a measles outbreak in Bangladesh has resulted in nearly 750 deaths, mostly among children, despite the country's previous progress in eliminating the disease. Meanwhile, a study has found that the MenB vaccine offers no protection against gonorrhoea, a common bacterial infection.
Why It Matters
The Pip review highlights the need for a more comprehensive and sustainable disability benefit system, with the cost of Pip expected to rise to over £41bn by 2030. The measles outbreak in Bangladesh underscores the importance of maintaining high vaccination rates and addressing the root causes of outbreaks. The ineffectiveness of the MenB vaccine against gonorrhoea emphasizes the need for continued research and development of effective vaccines.
What Experts Say
"The Pip system is not working for millions of disabled people or the government, and needs fundamental change." — Sir Stephen Timms, Disability Minister
"We have never seen an outbreak this huge... The true numbers are likely to be higher, given the sudden surge and overwhelmed health system." — Dr. Mohammed Golam Mawla, Paediatrician
Background
The Pip system was introduced in 2013 to replace the Disability Living Allowance (DLA). The system has been criticized for its complexity and the difficulties faced by applicants. The measles outbreak in Bangladesh has been attributed to a decline in vaccination rates, which had previously been above 90%. The MenB vaccine was introduced to prevent meningitis B, but its effectiveness against gonorrhoea was unknown until the recent study.
What Comes Next
As the UK government reviews the Pip system, it must prioritize a more sustainable and effective disability benefit system. In Bangladesh, efforts to address the measles outbreak and maintain high vaccination rates are crucial. The development of effective vaccines against gonorrhoea and other diseases remains a pressing concern. As the world grapples with heatwaves and healthcare challenges, it is essential to prioritize comprehensive and sustainable solutions.
What Happened
The UK's Personal Independence Payments (Pip) system, a key disability benefit, has been deemed "not fit for purpose" by Sir Stephen Timms, the minister leading a review into the system. The review found that the process of applying for the benefit was "dehumanising" and a barrier to work. In other news, a measles outbreak in Bangladesh has resulted in nearly 750 deaths, mostly among children, despite the country's previous progress in eliminating the disease. Meanwhile, a study has found that the MenB vaccine offers no protection against gonorrhoea, a common bacterial infection.
Why It Matters
The Pip review highlights the need for a more comprehensive and sustainable disability benefit system, with the cost of Pip expected to rise to over £41bn by 2030. The measles outbreak in Bangladesh underscores the importance of maintaining high vaccination rates and addressing the root causes of outbreaks. The ineffectiveness of the MenB vaccine against gonorrhoea emphasizes the need for continued research and development of effective vaccines.
What Experts Say
"The Pip system is not working for millions of disabled people or the government, and needs fundamental change." — Sir Stephen Timms, Disability Minister
"We have never seen an outbreak this huge... The true numbers are likely to be higher, given the sudden surge and overwhelmed health system." — Dr. Mohammed Golam Mawla, Paediatrician
Background
The Pip system was introduced in 2013 to replace the Disability Living Allowance (DLA). The system has been criticized for its complexity and the difficulties faced by applicants. The measles outbreak in Bangladesh has been attributed to a decline in vaccination rates, which had previously been above 90%. The MenB vaccine was introduced to prevent meningitis B, but its effectiveness against gonorrhoea was unknown until the recent study.
What Comes Next
As the UK government reviews the Pip system, it must prioritize a more sustainable and effective disability benefit system. In Bangladesh, efforts to address the measles outbreak and maintain high vaccination rates are crucial. The development of effective vaccines against gonorrhoea and other diseases remains a pressing concern. As the world grapples with heatwaves and healthcare challenges, it is essential to prioritize comprehensive and sustainable solutions.